Gyrodyne (GYRO) Stock Price, News & Analysis

Company Overview

Gyrodyne Company of America, Inc. (NASDAQ: GYRO) operates as a diversified real estate and healthcare services company. Through its real estate segment, the company holds a portfolio of properties on Long Island, New York, including residential, mixed-use and land development sites. Gyrodyne’s holdings encompass both fully leased properties and parcels earmarked for future development, allowing the company to generate stable rental income while pursuing capital appreciation over the long term.

In parallel with its real estate activities, Gyrodyne provides hospice and palliative care services through its subsidiary, WRS Group. This healthcare arm delivers end-of-life medical care, counseling and bereavement support to patients and families across New York and Florida. The company’s interdisciplinary team of nurses, social workers and chaplains works in home-based, inpatient and outpatient settings, focusing on personalized care plans and community outreach to ensure broad access to its programs.

Originally founded in 1966 to develop and manufacture unmanned rotorcraft, Gyrodyne pivoted away from aerospace in the 1980s, selling its manufacturing operations and transitioning into real estate investment and healthcare services. Over the decades, the company has steadily built its real estate portfolio through strategic land acquisitions and leasing agreements, while selectively expanding its hospice business to meet growing demand for compassionate, patient-centered care.

Gyrodyne is led by President and Chief Executive Officer William P. Higgins Jr., who brings extensive experience in both real estate development and healthcare management. Under his leadership, the company continues to balance its dual-segment strategy by optimizing property utilization on Long Island and enhancing the geographic reach of its hospice services. Gyrodyne’s board of directors maintains oversight of corporate governance and strategic planning, positioning the company for sustainable growth in its chosen markets.

Key Stats

• Today's Range: $8.51 to $8.81
• 50-Day Range: $7.94 to $9.36
• 52-Week Range: $6.80 to $11.96
• Volume: 1,728 shs
• Average Volume: 2,145 shs
• Market Capitalization: $19.22 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Gyrodyne Stock Analysis - MarketRank™

Gyrodyne scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Gyrodyne .

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Gyrodyne has a P/B Ratio of 0.45. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.04% of the float of Gyrodyne has been sold short.

Short Interest Ratio / Days to Cover

Gyrodyne has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Gyrodyne has recently decreased by 14.29%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Gyrodyne does not currently pay a dividend.

Dividend Growth

Gyrodyne does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.04% of the float of Gyrodyne has been sold short.

Short Interest Ratio / Days to Cover

Gyrodyne has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Gyrodyne has recently decreased by 14.29%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Gyrodyne this week, compared to 0 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gyrodyne insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.10% of the stock of Gyrodyne is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

71.36% of the stock of Gyrodyne is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GYRO Stock Analysis - Frequently Asked Questions

How have GYRO shares performed this year?

Gyrodyne 's stock was trading at $9.02 at the beginning of the year. Since then, GYRO stock has decreased by 3.2% and is now trading at $8.7350.

How do I buy shares of Gyrodyne ?

Shares of GYRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Gyrodyne own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Gyrodyne investors own include Meta Platforms (META), Acasti Pharma (ACST), Amyris (AMRS), Ariad Pharmaceuticals (ARIA), Astrotech (ASTC), Athersys (ATHX) and (AVNR) (AVNR).

Company Calendar

• Today: 7/22/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: REAL ESTATE OPS
• Sub-Industry: Diversified REITs
• Current Symbol: NASDAQ:GYRO
• CIK: 1589061
• Web: www.gyrodyne.com
• Phone: (631) 584-5400
• Fax: 631-584-7075
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $4.86 million
• Price / Sales: 3.95
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $19.51 per share
• Price / Book: 0.45

Miscellaneous

• Outstanding Shares: 2,199,000
• Free Float: 1,933,000
• Market Cap: $19.21 million
• Optionable: Not Optionable
• Beta: 0.37